[Table/Fig-1]:
Age (in years) |
Immunocompromised Group (n=30) |
Immunocompetent Group (n=30) |
Total |
---|---|---|---|
No.(%age) | No.(%age) | No.(%age) | |
20-40 | 11(36.7%) | 9(30.0%) | 20(33.3%) |
41-60 | 15(50.0%) | 11(36.7%) | 26(43.3%) |
>60 | 4(13.3%) | 10(33.3%) | 14(23.3%) |